Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02068183 · ClinicalTrials.gov registry record

World Trade Center Adolescent Health Study

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
402
Enrollment target

NCT02068183 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 402 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02068183 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
402 participants
Enrollment target

Study Summary

The proposed study builds upon preliminary studies in self-selected populations to identify opportunities for early identification of World Trade Center-related health consequences in adolescents. If adverse health consequences are identified, proactive cardiometabolic and pulmonary screening of exposed children may be indicated, with targeted interventions intended to prevent development of chronic obstructive pulmonary disease, and adverse cardiometabolic outcomes in adulthood.

Trial Details

FieldValue
Enrollment Target 402 participants
Start Date 2013-12
Est. Completion 2016-03

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02068183

The ClinicalTrials.gov registry entry for NCT02068183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02068183 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02068183 about?

NCT02068183 is a clinical study titled "World Trade Center Adolescent Health Study". The proposed study builds upon preliminary studies in self-selected populations to identify opportunities for early identification of World Trade Center-related health consequences in adolescents. If adverse health consequences are identified, proactive cardiometabolic and pulmonary screening of exp...

What is the current status of trial NCT02068183?

This trial is currently completed. The enrollment target is 402 participants. The study started on 2013-12. Estimated completion is 2016-03.

Who is sponsoring clinical trial NCT02068183?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.